Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 31-40 of 69

Page
per page
  1. CL-387785 (EKI-785)
    B5899 CL-387785 (EKI-785)
    Summary: Irreversible inhibiter of EGFR
      insoluble in EtOH; insoluble in H2O; ≥16.85 mg/mL
  2. Olmutinib (HM61713, BI 1482694)
    B7813 Olmutinib (HM61713, BI 1482694)
    Summary: EGFR mutant-specific inhibitor
  3. NSC228155
    B7815 NSC228155
    Summary: EGFR activator
      ≥29 mg/mL
  4. EGFR/ErbB2 Inhibitor
    C3285 EGFR/ErbB2 Inhibitor
    Summary: EGFR and c-ErbB2 inhibitor
      ≤1 mg/mL
  5. EGFR Inhibitor
    C3327 EGFR Inhibitor
    Summary: EGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥60.7 mg/mL
  6. 4-methyl Erlotinib
    C4727 4-methyl Erlotinib
    Summary: EGFR inhibitor
      ≤0.25 mg/mL
  7. AG-82
    C4760 AG-82
    Summary: inhibitor of EGFR kinase
      ≤20 mg/mL
  8. RG-14620
    C4766 RG-14620
    Summary: inhibitor of epidermal growth factor (EGF) receptor kinase
      ≤1 mg/mL
  9. AG-213
    C4770 AG-213
    Summary: inhibitor of epidermal growth factor (EGF) receptor kinase
      ≤10 mg/mL
  10. AG-183
    C4844 AG-183
    Summary: inhibitor of epidermal growth factor (EGF) receptor kinase
      ≤20 mg/mL

Items 31-40 of 69

Page
per page